Zealand Pharma · 10 hours ago
Senior Director, Market Access Strategy
New Jersey / New York / PA
Full-time
Onsite
Director/Executive
$245K/yr - $300K/yr
10+ years expZealand Pharma is a biotechnology company focused on the discovery and development of peptide-based medicines, and they are seeking a dynamic and experienced leader to serve as the Senior Director, Market Access Strategy and Execution. This role is critical in shaping and executing the company’s access strategy for upcoming launches in rare diseases and obesity, requiring collaboration across internal teams and external partners to ensure patient access and commercial success.
BiopharmaBiotechnologyHealth Care
Responsibilities
Develop and lead the US market access strategy for Zealand Pharma’s rare disease portfolio, ensuring alignment across pricing, reimbursement, distribution, patient support, and affordability programs
Lead access strategy and execution for obesity therapy in partnership with a commercialization partner, balancing independence with joint commercialization needs
Define the value proposition for different payer and stakeholder segments
Collaborate with Medical Affairs, HEOR, and Commercial teams to identify evidence needs, develop economic models, and shape compelling, payer-relevant scientific messaging
Drive payer segmentation to identify and prioritize key archetypes, including commercial plans, PBMs, Medicare, and Medicaid stakeholders
Develop and execute engagement strategies to influence access, reimbursement, and pricing outcomes
Contribute to pricing and contracting strategies, including WAC recommendations, discount modeling, and forecasting, in collaboration with Finance and Brand leadership
Monitor evolving payer market dynamics and propose innovative solutions to secure access
Oversee the development of payer-facing resources, pull-through tools, and affordability initiatives
Lead vendor and consultant partnerships supporting access landscape assessments and tactical execution
Ensure integration of access strategy into launch planning, patient journey design, and sales force training
Represent market access in internal planning forums and external alliance management settings
Explore and implement innovative access and contracting approaches, including value-based agreements and novel payer collaborations to improve patient access
Qualification
Required
10+ years of US Market Access experience within biotech/pharma, a national payer, or a pharmacy benefit manager (PBM)
Successful track record of leading product launch strategies including pricing, reimbursement, and formulary access
Experience with national payer/PBM formulary strategy development and implementation
Deep understanding of US payer and PBM ecosystems, including retail and specialty pharmacy dynamics, rebate structures, and access barriers
Strong grasp of employer and health plan segmentation and the incentive structures that influence formulary decision-making
Proven ability to lead cross-functional teams and work effectively with alliance partners in co-commercialization environments
Exceptional communication, strategic thinking, and presentation skills with the ability to influence executive-level stakeholders
Company
Zealand Pharma
Zealand Pharma is a biotechnology company that offers scientific expertise in turning peptides into medicines.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.59BKey Investors
European Investment BankOberland CapitalAthyrium Capital Management LP
2025-06-06Post Ipo Equity· $4.14M
2024-06-25Post Ipo Equity· $1.01B
2024-01-08Post Ipo Equity· $212.88M
Leadership Team
Adam Steensberg
President and CEO
Rachel James-Owens
Vice President Corporate Communications & Media Relations
Recent News
2026-01-11
2026-01-07
Company data provided by crunchbase